Axsome Therapeutics, Inc. short interest in 2025
In 2025, Axsome Therapeutics, Inc.'s disclosed short interest ran from 11.87% of shares outstanding on 15 Jan 2025 to 5.40% on 31 Dec 2025, a change of -6.47 percentage points. The year's high was 12.03% on 14 Feb 2025 and its low 5.40% on 31 Dec 2025, averaging 8.29% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.16 days on 31 Mar 2025. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.87% (15 Jan 2025)
- End of year
- 5.40% (31 Dec 2025)
- Change
- -6.47 pp
- High
- 12.03% (14 Feb 2025)
- Low
- 5.40% (31 Dec 2025)
- Average
- 8.29%
- Highest days to cover
- 9.16 (31 Mar 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 11.87% | 5.76 | results (8-K) |
| 31 Jan 2025 | 11.57% | 5.84 | |
| 14 Feb 2025 | 12.03% | 4.55 | |
| 28 Feb 2025 | 11.71% | 5.59 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 10.06% | 8.04 | |
| 31 Mar 2025 | 10.56% | 9.16 | |
| 15 Apr 2025 | 9.07% | 3.93 | |
| 30 Apr 2025 | 8.52% | 6.92 | |
| 15 May 2025 | 7.89% | 5.64 | 10-Q filed, results (8-K) |
| 30 May 2025 | 7.89% | 7.80 | |
| 13 Jun 2025 | 8.16% | 5.93 | |
| 30 Jun 2025 | 8.29% | 5.49 | |
| 15 Jul 2025 | 7.37% | 6.04 | |
| 31 Jul 2025 | 7.36% | 5.74 | |
| 15 Aug 2025 | 7.46% | 6.60 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 7.03% | 6.09 | |
| 15 Sep 2025 | 6.92% | 5.62 | |
| 30 Sep 2025 | 6.78% | 7.13 | |
| 15 Oct 2025 | 6.89% | 7.43 | |
| 31 Oct 2025 | 7.15% | 7.92 | |
| 14 Nov 2025 | 6.73% | 5.48 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 6.75% | 6.01 | |
| 15 Dec 2025 | 5.62% | 5.80 | |
| 31 Dec 2025 | 5.40% | 3.84 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.